GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2019, CASH DIVIDEND DECLARATION AND TRADING STATEMENT

Highlights


Revenue 
+9.3%
to R25.7 billion


Normalised EBITDA
+3.5%
to R5.7 billion

Normalised earnings per share
+5.6%
to 116.4 cents


Cash generated from operations
+7.7%
to R5.9 billion

Final dividend of 53 cents per share
+6.0%

Downloads

DOWNLOADS

VIEW WEBCAST

Financials

Commentary

OVERVIEW

Life Healthcare delivered a healthy overall performance, despite challenging trading environments in most of the markets in which we operate. The strong revenue growth of 9.3% is a result of robust volume growth in the PET-CT contract in the United Kingdom and a strong H2 FY2019 performance in southern Africa.